History of leptomeningeal disease
Patient must not have leptomeningeal disease
Leptomeningeal disease
Leptomeningeal disease
Leptomeningeal disease as the only manifestation of the current malignancy
Multifocal disease or leptomeningeal disease (LM) disease on post-operative MRI;
History of leptomeningeal disease;
History of leptomeningeal metastatic disease
Leptomeningeal disease
Leptomeningeal involvement of cancer
Leptomeningeal disease
Patients with leptomeningeal disease are not eligible for participation\r\n* Please note: leptomeningeal enhancement is not an exclusion
Leptomeningeal disease
Known leptomeningeal disease
Known leptomeningeal or brainstem metastases (defined as positive CSF cytology and/or unequivocal radiological evidence of clinically significant leptomeningeal involvement; CSF sampling is not required in the absence of suggestive symptoms to exclude leptomeningeal involvement)
Participants with widespread, definitive leptomeningeal disease
Participants with widespread, definitive leptomeningeal disease
Leptomeningeal disease
Patients with leptomeningeal disease
Patients with metastatic disease, including leptomeningeal or subarachnoid disseminated disease.
Leptomeningeal disease
Has evidence of leptomeningeal disease
Patient has leptomeningeal disease
History of leptomeningeal disease
Diffuse leptomeningeal gliomatosis
History of leptomeningeal disease
Untreated CNS or leptomeningeal metastasis\r\n* Note: CNS or leptomeningeal disease must be stable for >= 3 months prior to registration
Patients with asymptomatic leptomeningeal disease are eligible for participation in this trial; however, patients who had progression of leptomeningeal disease on alectinib will be required to undergo CNS radiation to meet eligibility
Patients with known leptomeningeal metastatic disease
Patients with leptomeningeal disease
Leptomeningeal disease
Symptomatic or untreated leptomeningeal disease
Leptomeningeal disease
Patients with metastatic disease, including leptomeningeal or subarachnoid disseminated disease
Has presence of diffuse leptomeningeal disease or extracranial disease
Leptomeningeal involvement regardless of treatment status
Leptomeningeal involvement regardless of treatment status
Leptomeningeal disease
Evidence of leptomeningeal disease
Subjects with leptomeningeal disease are excluded
Presence of leptomeningeal disease
Diagnosis of leptomeningeal disease
Evidence of leptomeningeal spread of disease
Presence of leptomeningeal disease
Presence of extracranial metastatic or leptomeningeal disease
Leptomeningeal disease
Leptomeningeal disease
Presence of leptomeningeal disease
Presence of diffuse leptomeningeal disease
Imaging or cytologic evidence of leptomeningeal disease
Patients with multifocal disease or leptomeningeal disease who require whole brain radiotherapy (WBRT)
Presence of leptomeningeal disease
Known leptomeningeal involvement.
Leptomeningeal disease
Patients who have leptomeningeal disease
Patients with leptomeningeal disease
Symptomatic or untreated leptomeningeal disease.
History of leptomeningeal disease
Has infratentorial, or leptomeningeal evidence of recurrent disease
Leptomeningeal disease
Evidence of leptomeningeal dissemination
Patients with documented evidence of leptomeningeal disease
Leptomeningeal disease
Leptomeningeal disease.
Leptomeningeal disease
Leptomeningeal disease
History of leptomeningeal disease
History of leptomeningeal disease
Leptomeningeal disease
Patients must not have clinical evidence of leptomeningeal disease (a spinal tap does not need to be performed)
Leptomeningeal disease
Has infratentorial, or leptomeningeal evidence of recurrent disease
Leptomeningeal disease
Has presence of diffuse leptomeningeal disease or extracranial disease
Leptomeningeal disease
Known leptomeningeal disease
Leptomeningeal disease
Presence of extracranial metastatic or leptomeningeal disease
Leptomeningeal disease
Patients with leptomeningeal disease are excluded
presence of Alzheimer's disease, meningioma, leptomeningeal disease from prostate cancer.
History of leptomeningeal disease
Patients with leptomeningeal disease are not eligible for participation
Patients with leptomeningeal disease
Infratentorial, or leptomeningeal evidence of recurrent disease
Symptomatic or untreated leptomeningeal disease
Patients with leptomeningeal disease
Multifocal disease or leptomeningeal spread
Evidence of leptomeningeal spread of glibolastoma or gliosarcoma.
Leptomeningeal disease as a manifestation of cancer
Leptomeningeal disease
Leptomeningeal disease as a manifestation of cancer
Any history of leptomeningeal disease
Leptomeningeal disease
History of leptomeningeal disease.
Symptomatic or untreated leptomeningeal disease
Leptomeningeal disease
Leptomeningeal disease as a manifestation of cancer
Leptomeningeal disease as a manifestation of cancer
Leptomeningeal disease
Leptomeningeal disease as the only manifestation of the current malignancy
Leptomeningeal disease
Leptomeningeal disease as the only manifestation of the current malignancy
Evidence of leptomeningeal spread of disease.
The participant has leptomeningeal disease.
Leptomeningeal disease as the only manifestation of the current malignancy
Presence of diffuse leptomeningeal disease or gliomatosis cerebri.
History of leptomeningeal disease
Leptomeningeal disease
Leptomeningeal disease
Diffuse leptomeningeal disease at recurrence
Leptomeningeal disease
Leptomeningeal disease
